Research status of long non-coding RNA MALAT1 in breast cancer

Author: Dandan SONG ¹ ; Xueyuan CHEN ¹ ; Ruiqi CHEN ¹ ; Hanqiao LI ¹ ; Tian WU ¹ ; Dandan SONG ² ; Xueyuan CHEN ² ; Ruiqi CHEN ² ; Hanqiao LI ² ; Tian WU ³
Author Information

1. The Third Xiangya Hospital, Central South University
2. Xiangya Medical College of Central South University
3. Xiangya School of Pharmaceutical Sciences, Central South University
Publication Type:Journal Article
Keywords: Breast cancer; Long non-coding RNA; Metastasis-related transcript 1 of lung adenocarcinoma
From: Chinese Journal of Clinical Pharmacology and Therapeutics 2021;26(1):49-57
CountryChina
Language:Chinese
Abstract: Long non-coding RNA (LncRNA) is a kind of RNA longer than 200nt, whose abnormal expression plays a significant role in the development of tumors. Metastasis-associated lung adenocarcinoma transcription 1 (MALAT1), as one of LncRNAs, is closely related to the pathogenesis of breast cancer. MALAT1 can affect the tumorigenesis and progression of breast cancer and is expected to be an effective target for the diagnosis and treatment of breast cancer. Herein, we review the research status of MALAT1 in breast cancer.